TIVC
Valion Bio, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$0.26
−10.46%Latest reported
- Last report date
- Mar 25, 2026
- EPS actual
- $6.68
- EPS estimate
- —
- Revenue actual
- $80.0K
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 8
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +89.6%
- Revenue beats (12Q)
- 0
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Mar 25, 2026 | — | $6.68 | — | $80.0K |
| Nov 14, 2025 | — | -$1.97 | — | $146.0K |
| Aug 14, 2025 | — | -$2.19 | — | $86.0K |
| May 15, 2025 | — | -$2.52 | — | $70.0K |
| Mar 21, 2025 | -$85 | -$15 | Beat 81.86% | $180.0K |
| Nov 14, 2024 | -$102 | -$3.91 | Beat 96.17% | $126.0K |
| Aug 14, 2024 | -$102 | -$5.44 | Beat 94.67% | $140.0K |
| May 15, 2024 | -$119 | -$17 | Beat 85.56% | $334.0K |
| Nov 14, 2023 | -$119 | -$25 | Beat 78.86% | $282.0K |
| Aug 14, 2023 | -$136 | -$119 | Beat 12.50% | $161.0K |
| Mar 31, 2023 | -$527 | -$391 | Beat 25.81% | $376.0K |
| Nov 14, 2022 | -$544 | -$459 | Beat 15.63% | $477.0K |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Aug 17, 2026